PATENT CLAIM ANALYSIS

Application Number: 16124269
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "054000"]

Abstract:
The present invention relates to the use of chondroitin as a transdermal carrier and slow-release system for active ingredients in pharmaceutical and cosmeceutical compositions.

Claim (Index 1):
Method of transdermal and trans-mucosa delivery of non-covalent complexes of non-sulphated chondroitin having a molecular weight between 5 and 100 kDa determined by size exclusion chromatography and active ingredients in a patient in need thereof, said method comprising\n applying said complexes on said skin or on said mucosa of said patient; and obtaining said transdermal and transmucosa delivery of said complexes, wherein said complexes are absorbed through mucous membranes and skin and wherein said complexes behave as transdermal carriers and slow-release system for said active ingredients.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.04167
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14400069', '14977119', '10896546', '13112696', '13322185']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7065936813696738
- 35 USC 102 Novelty (BERT): 0.4993297474227302
- Combined Prediction Score: 0.6858672879749794
- Mean Citation Score: 134.57041099999998
- Max Citation Score: 175.5527
- Similarity Product: 109.82917685570716

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test